|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel. |
| 公司地址
| Central District, Kibbutz Glil Yam, ISR, 4690500 |
| 電話號碼
| +972 773603504 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.imcannabis.com |
| 員工數量
| 55 |
| Mr. Uri Birenberg |
Chief Financial Officer |
美元 330.24K |
31/03/2025 |
| Mr. Oren Shuster |
Executive Chairman of the Board and Chief Executive Officer |
美元 484.70K |
31/03/2025 |
| Mr. Richard Balla |
Chief Executive Officer, Adjupharm |
美元 193.61K |
31/03/2025 |
| Mr. Eyal Fisher |
Chief Executive Officer of IMC Holdings |
美元 262.20K |
31/03/2025 |
| Ms. Michal Lebovitz Nissimov |
General Counsel |
美元 192.88K |
31/03/2025 |
|
|
| Mr. Shmulik Arbel |
Independent Director |
31/03/2025 |
| Mr. Moti Marcus |
Independent Director |
31/03/2025 |
| Ms. Einat Zakariya |
Independent Director |
31/03/2025 |
| Mr. Oren Shuster |
Executive Chairman of the Board and Chief Executive Officer |
31/03/2025 |
| Mr. Brian Schinderle |
Independent Director |
31/03/2025 |
|
|
|
|
